Xentria and Meitheal Pharmaceuticals Announce Exclusive Licensing Agreement for XTMAB-16 in North America Read more
Innovent and RemeGen Enter into Clinical Trial Collaboration Investigating Combination Therapy of TYVYT (sintilimab injection) and Novel ADC Candidates for Advanced Solid Tumors in China Read more
Brii Biosciences Announces Entry into Definitive Agreements from Sale of its Equity Interest in Qpex Biopharma and Acquiring Exclusive Global Rights for BRII-693 Read more
ASLAN Pharmaceuticals Enters Into a Strategic Licensing Deal With Zenyaku Kogyo for the Development and Commercialization of Eblasakimab in Japan Read more
FDA approves Jardiance (empagliflozin) for the treatment of type 2 diabetes in children 10 years and older Read more
FDA GRANTS FULL APPROVAL FOR BLINCYTO (BLINATUMOMAB) TO TREAT MINIMAL RESIDUAL DISEASE-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA Read more
Ultragenyx Opens New Gene Therapy Manufacturing Facility in Bedford, Continuing its Expansion in Massachusetts Read more